1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 64 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trialChow, E.; Meyer, R.; Chen, B.; van der Linden, Y.; Roos, D.; Hartsell, W.; Hoskin, P.; Wu, J.; Nabid, A.; Tissing-Tan, C.; Oei, B.; Babington, S.; Demas, W.; Wilson, C.; Wong, R.; Brundage, M.
2014Individual characteristics associated with physical activity intervention delivery mode preferences among adultsShort, C.; Vandelanotte, C.; Duncan, M.
2014A 16-year prospective study of community-onset bacteremic Acinetobacter pneumoniaDavis, J.; McMillan, M.; Swaminathan, A.; Kelly, J.; Piera, K.; Baird, R.; Currie, B.; Anstey, N.
2014LgG4 immunostaining and its implications in orbital inflammatory diseaseWong, A.; Planck, S.; Choi, D.; Harrington, C.; Troxell, M.; Houghton, D.; Stauffer, P.; Wilson, D.; Grossniklaus, H.; Dailey, R.; Ng, J.; Steele, E.; Harris, G.; Czyz, C.; Foster, J.; White, V.; Dolman, P.; Kazim, M.; Patel, P.; Edward, D.; et al.; Wallace, G.
2014IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylationSmith, E.; Ruszkiewicz, A.; Jamieson, G.; Drew, P.
2014Added value of soluble tumor necrosis factor-alpha receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetesForsblom, C.; Moran, J.; Harjutsalo, V.; Loughman, T.; Waden, J.; Tolonen, N.; Thorn, L.; Saraheimo, M.; Gordin, D.; Groop, P.; Thomas, M.
2014Weight gain on androgen deprivation therapy: which patients are at highest risk?Seible, D.; Gu, X.; Hyatt, A.; Beard, C.; Choueiri, T.; Efstathiou, J.; Miyamoto, D.; Mitin, T.; Martin, N.; Sweeney, C.; Trinh, Q.; Beckman, J.; Basaria, S.; Nguyen, P.
2014Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)Falchook, G.; Long, G.; Kurzrock, R.; Kim, K.; Arkenau, H.; Brown, M.; Hamid, O.; Infante, J.; Millward, M.; Pavlick, A.; Chin, M.; O'Day, S.; Blackman, S.; Curtis, C.; Lebowitz, P.; Ma, B.; Ouellet, D.; Kefford, R.
2014Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trialNicholls, S.J.; Kastelein, J.J.P.; Schwartz, G.G.; Bash, D.; Rosenson, R.S.; Cavender, M.A.; Brennan, D.M.; Koenig, W.; Jukema, J.W.; Nambi, V.; Wright, R.S.; Menon, V.; Lincoff, A.M.; Nissen, S.E.
2014Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cellsNievergall, E.; Ramshaw, H.; Yong, A.; Biondo, M.; Busfield, S.; Vairo, G.; Lopez, A.; Hughes, T.; White, D.; Hiwase, D.

Discover